ORAMED PHARMACEUTICALS INC. Public Float
ORAMED PHARMACEUTICALS INC. (ORMP) had Public Float of $77.66 million as of 2025-06-30, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-26
- 2025-06-30: Entity Public Float $77.66M.
- 2024-06-30: Entity Public Float $131.19M.
- 2023-06-30: Entity Public Float $130.53M.
- 2022-06-30: Entity Public Float $169.59M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $77.66M 10-K · filed 2026-03-26 |
| 2024-06-30 | $131.19M 10-K/A · filed 2025-07-16 |
| 2023-06-30 | $130.53M 10-K · filed 2024-03-06 |
| 2022-06-30 | $169.59M 10-K · filed 2023-03-06 |
| 2021-02-28 | $227.77M 10-K · filed 2021-11-24 |
| 2020-02-29 | $60.80M 10-K · filed 2020-11-24 |
| 2019-02-28 | $42.51M 10-K · filed 2019-11-27 |
| 2018-02-28 | $74.40M 10-K · filed 2018-11-28 |
| 2017-02-28 | $56.75M 10-K · filed 2017-11-29 |
| 2016-02-29 | $73.58M 10-K · filed 2016-11-25 |
| 2015-02-28 | $44.47M 10-K · filed 2015-11-25 |
| 2014-02-28 | $128.91M 10-K · filed 2014-11-14 |
| 2013-02-28 | $52.69M 10-K · filed 2013-11-27 |
| 2012-02-29 | $17.49M 10-K · filed 2012-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |